GALERA THERAPEUTICS INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GRTX and buy or sell other stocks, ETFs, and their options commission-free!

About GRTX

Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. 

CEO
John Mel Sorensen
CEOJohn Mel Sorensen
Employees
3
Employees3
Headquarters
Malvern, Pennsylvania
HeadquartersMalvern, Pennsylvania
Founded
2009
Founded2009
Employees
3
Employees3

GRTX Key Statistics

Market cap
2.06M
Market cap2.06M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
—
Dividend yield—
Average volume
82.74K
Average volume82.74K
High today
$0.0245
High today$0.0245
Low today
$0.0226
Low today$0.0226
Open price
$0.0241
Open price$0.0241
Volume
33.85K
Volume33.85K
52 Week high
$0.0849
52 Week high$0.0849
52 Week low
$0.021
52 Week low$0.021

People also own

Based on the portfolios of people who own GRTX. This list is generated using Robinhood data, and it’s not a recommendation.
Ocugen, Inc
Nikola
Camber Energy
Mullen Automotive
Ideanomics
Cenntro Inc.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.